Form 4: Ultragenyx Exec Reports Stock Transactions

Ultragenyx Pharmaceutical Inc. EVP Dennis Karl Huang reported the conversion of performance stock units into 11,137 shares and the disposition of 999 shares for tax withholdings.

Summary

• Dennis Karl Huang, EVP, Chief Technical Operations Officer of Ultragenyx Pharmaceutical Inc. (RARE), acquired 11,137 shares of common stock on March 1, 2026.
• These shares were obtained from the conversion of previously granted performance stock units (PSUs) upon certification of the performance metric, with a transaction price of $0.
• Following this acquisition, Mr. Huang's beneficial ownership increased to 125,728 shares.
• On March 2, 2026, Mr. Huang disposed of 999 shares of common stock at a price of $23.39 per share.
• This disposition was to cover required tax withholdings due to the vesting of Restricted Stock Units (RSUs).
• After both transactions, Mr. Huang's beneficial ownership stands at 124,729 shares, which includes previously reported shares underlying RSUs subject to vesting conditions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive. The conversion of performance stock units indicates the achievement of internal company goals, while the subsequent sale for tax purposes is a routine, neutral event.

Positives

• The conversion of 11,137 performance stock units into common stock indicates that specific performance metrics were met, reflecting positively on the company's operational achievements.

Negatives

• The disposition of 999 shares for tax withholdings represents a reduction in the executive's direct ownership, although it is a routine event associated with RSU vesting.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as the vesting of equity awards and subsequent sales for tax purposes, are common occurrences in publicly traded companies, particularly in the biotechnology sector where executive compensation often includes significant equity components. The conversion of performance-based units suggests the company met internal targets, which is generally a positive indicator for operational execution.

Stakeholder Impact

• Shareholders: The increase in beneficial ownership from PSU conversion could be seen as a positive signal of executive alignment with shareholder interests, while the tax-related sale is a minor, routine event with negligible impact on overall share float or price.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of performance stock units and the sale of shares for tax withholdings. These events do not provide significant new information to warrant a change in investment thesis or a strong buy/sell recommendation. The achievement of performance metrics for PSU conversion is a positive operational sign, but the overall impact on the company's valuation or future prospects is neutral, thus a 'hold' recommendation is appropriate.

Keywords

Ultragenyx, RARE, Form 4, Insider Transaction, Performance Stock Units, Restricted Stock Units, Executive Compensation, Stock Ownership